Literature DB >> 12949383

Improved glucose tolerance with lifetime diet restriction favorably affects disease and survival in dogs.

Brian T Larson1, Dennis F Lawler, Edward L Spitznagel, Richard D Kealy.   

Abstract

Labrador retrievers (42 of original 48) were used to assess the effects of lifetime diet restriction on glucose tolerance at ages 9-12 y. Restricted-fed (RF) dogs were fed 75% of the same diet consumed by control-fed (CF) pair-mates. An intravenous glucose tolerance test was done annually (maximal stimulation, nonsteady-state). Diet treatment, age, and interactions were fixed effects. Statistical procedures used included mixed-model, repeated-measures ANOVA; least-squares means; Tukey's multiple comparison; paired t tests; and Spearman rank correlations. Glucose k-value and half-life, and insulin sensitivity (total, and 9, 10, 11 y, and per lean mass) were higher (P < 0.05) in RF than in CF dogs. Late-phase insulin release [area under the curve (AUC) 30-120 min] was less (P < 0.05) in RF than in CR dogs. Early-phase insulin release (AUC 0-5 min), y 12 insulin sensitivity and insulinogenic index did not differ between RF and CF dogs. Insulin peak, delta and total AUC increased (P < 0.05) with age, whereas the glucose k-value and glucose half-life were not affected by age. Insulin sensitivity was negatively, and insulin AUC 30-120 min, peak and delta glucose were positively correlated with body weight, body condition score, fat mass, percentage of fat and abdominal fat/total tissue. Higher insulinogenic indices tended (P = 0.053) to be associated with greater median survival and dogs with higher insulin sensitivity were at lower (P < 0.05) risk of dying or receiving chronic disease treatment. Time to first osteoarthritis treatment or death was greater with lower basal glucose and higher insulin sensitivity (P < 0.05), but diet restriction explained most of this relationship's variation. Glucose disposal efficiency and insulin response were associated with increased quality and length of life in diet-restricted dogs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949383     DOI: 10.1093/jn/133.9.2887

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

1.  Calorie restriction leads to greater Akt2 activity and glucose uptake by insulin-stimulated skeletal muscle from old rats.

Authors:  Haiyan Wang; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

2.  Effect of fish and krill oil supplementation on glucose tolerance in rabbits with experimentally induced obesity.

Authors:  Zhenya Ivanova; Bodil Bjørndal; Natalia Grigorova; Anton Roussenov; Ekaterina Vachkova; Kjetil Berge; Lena Burri; Rolf Berge; Spaska Stanilova; Anelia Milanova; Georgi Penchev; Rita Vik; Vladimir Petrov; Teodora Mircheva Georgieva; Boycho Bivolraski; Ivan Penchev Georgiev
Journal:  Eur J Nutr       Date:  2014-10-15       Impact factor: 5.614

3.  Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock.

Authors:  James M Harper; Stephen J Durkee; Michael Smith-Wheelock; Richard A Miller
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

4.  Genetic mapping of principal components of canine pelvic morphology.

Authors:  Mark J Fealey; Joy Li; Rebel J E Todhunter; Ursula Krotscheck; Kei Hayashi; Marina J McConkey; Adam R Boyko; Jessica J Hayward; Rory J Todhunter
Journal:  Canine Genet Epidemiol       Date:  2017-03-24

5.  Canine Geriatric Syndrome: A Framework for Advancing Research in Veterinary Geroscience.

Authors:  Brennen A McKenzie; Frances L Chen; Margaret E Gruen; Natasha J Olby
Journal:  Front Vet Sci       Date:  2022-04-21

6.  Association between life span and body condition in neutered client-owned dogs.

Authors:  Carina Salt; Penelope J Morris; Derek Wilson; Elizabeth M Lund; Alexander J German
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.